CytoMed Therapeutics Limited’s (GDTC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting CytoMed Therapeutics Limited is a Buy.
CytoMed Therapeutics Limited’s (GDTC) 20-Day exponential moving average is $0.89, while CytoMed Therapeutics Limited’s (GDTC) share price is $0.84, making it a Sell.
CytoMed Therapeutics Limited’s (GDTC) 50-Day exponential moving average is $0.90, while CytoMed Therapeutics Limited’s (GDTC) share price is $0.84, making it a Sell.
CytoMed Therapeutics Limited’s (GDTC) 10-Day exponential moving average is $0.88, while CytoMed Therapeutics Limited’s (GDTC) share price is $0.84, making it a Sell.
CytoMed Therapeutics Limited’s (GDTC) 100-Day exponential moving average is $0.94, while CytoMed Therapeutics Limited’s (GDTC) share price is $0.84, making it a Sell.
CytoMed Therapeutics Limited’s (GDTC) stock price is $0.84 and CytoMed Therapeutics Limited’s (GDTC) 50-day simple moving average is $0.89, creating a Sell signal.
CytoMed Therapeutics Limited’s (GDTC) stock price is $0.84 and CytoMed Therapeutics Limited’s (GDTC) 100-day simple moving average is $0.92, creating a Sell signal.
CytoMed Therapeutics Limited’s (GDTC) stock price is $0.84 and CytoMed Therapeutics Limited’s (GDTC) 200-day simple moving average is $0.98, creating a Sell signal.